Effectiveness of Netarsudil versus Brimonidine in Eyes already Being Treated with Glaucoma Medications at a Single Academic Tertiary Care Practice: A Comparative Study

BACKGROUND: Rho kinase inhibitors, such as netarsudil, are a relatively new class of medications recently introduced into the market for the treatment of glaucoma, the leading cause of irreversible blindness in the world. Previous clinical trials have studied netarsudil's efficacy when used as...

Descripción completa

Detalles Bibliográficos
Autores principales: Pham, Alex T., Bradley, Chris, Casey, Corinne, Jampel, Henry D., Ramulu, Pradeep Y., Yohannan, Jithin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792385/
https://www.ncbi.nlm.nih.gov/pubmed/36582193
http://dx.doi.org/10.1016/j.curtheres.2022.100689

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792385/
https://www.ncbi.nlm.nih.gov/pubmed/36582193
http://dx.doi.org/10.1016/j.curtheres.2022.100689

Ejemplares similares